The human gut microbiome contains the largest number of bacteria in the body and has the
potential to greatly influence metabolism, not only locally but also systemically. There is an …

Cirrhosis–the common end-stage of chronic liver disease–is associated with a cascade of
events, of which intestinal bacterial overgrowth and dysbiosis are central. Bacterial toxins …

Background Chronic unpredictable mild stress (CUMS) can not only lead to depression-like
behavior but also change the composition of the gut microbiome. Regulating the gut …

Diverticula are outpouchings of the intestinal wall and are common anatomical alterations
detected in the human colon. Colonic diverticulosis (the presence of diverticula in the colon; …

Non-alcoholic fatty liver disease (NAFLD) is frequently associated with metabolic disorders,
being highly prevalent in obese and diabetic patients. Many concomitant factors that …

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease
worldwide. The intricate NAFLD pathogenesis is summarized by the multiple-hits …

Inflammatory bowel diseases (IBD) are chronic medical disorders characterized by recurrent
gastrointestinal inflammation. While the etiology of IBD is still unknown, the pathogenesis of …

Alcohol-related liver disease is associated with significant changes in gut microbial
composition. The transmissibility of ethanol-induced liver disease has been demonstrated …

The gut microbiota is a rich and dynamic ecosystem that actively interacts with the human
body, playing a significant role in the state of health and disease of the host. Diet, exercise …

Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of dysregulated lipid
and glucose metabolism, which is often associated with obesity, dyslipidemia and insulin …